B-MS Foundation funding for hep C prevention and education

The Bristol-Myers Squibb Foundation has announced funding of more than $1.17 million, focused on hepatitis C prevention and education and the  mitigation of the disease in China, India, and Taiwan. The funding is  part of Delivering Hope, an umbrella program for US drug major  Bristol-Myers Squibb's efforts in the areas of hepatitis awareness,  prevention and care. Organizations receiving funding are:

- The Liver Disease Prevention and Treatment Research Foundation  (Taiwan), which will create a training program for patients and  community-based health care providers in detection, care, and  management of patients and provide access to treatment in remote areas;

- The Liver Foundation/West Bengal (India), which will conduct a survey  on the impact of liver disease and hepatitis C and utilize the findings  to inform public health policy and foster prevention and awareness  activities in at risk populations;